Literature DB >> 19671807

The many myths of erythrocyte sedimentation rate and C-reactive protein.

Frederick Wolfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19671807     DOI： 10.3899/jrheum.090386

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Revising DAS28 scores for remission in rheumatoid arthritis.

Authors:  Claire Sheehy; Verity Evans; Heather Hasthorpe; Chetan Mukhtyar
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

2.  ERAMRS: a new MR scoring system for early rheumatoid arthritis of the wrist.

Authors:  Fan Xiao; James F Griffith; Andrea L Hilkens; Jason C S Leung; Jiang Yue; Ryan K L Lee; David K W Yeung; Lai-Shan Tam
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

3.  Relationship between anti-CCP antibodies and oxidant and anti-oxidant activity in patients with rheumatoid arthritis.

Authors:  Levent Ediz; Ozcan Hiz; Halil Ozkol; Elif Gulcu; Murat Toprak; Mehmet Fethi Ceylan
Journal:  Int J Med Sci       Date:  2011-02-09       Impact factor: 3.738

4.  Preoperatively elevated serum inflammatory markers increase the risk of periprosthetic joint infection following total knee arthroplasty in patients with osteoarthritis.

Authors:  Chi Xu; Heng Guo; Pengfei Qu; Jun Fu; Feng-Chih Kuo; Ji-Ying Chen
Journal:  Ther Clin Risk Manag       Date:  2018-09-17       Impact factor: 2.423

5.  Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies.

Authors:  Jeffrey R Curtis; Michael E Weinblatt; Nancy A Shadick; Cecilie H Brahe; Mikkel Østergaard; Merete Lund Hetland; Saedis Saevarsdottir; Megan Horton; Brent Mabey; Darl D Flake; Rotem Ben-Shachar; Eric H Sasso; T W Huizinga
Journal:  Arthritis Res Ther       Date:  2021-01-04       Impact factor: 5.156

6.  Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.

Authors:  Lieh-bang Liou; Wen-pin Tsai; Chee J Chang; Wan-ju Chao; Meng-hsin Chen
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

7.  Impact of rheumatoid arthritis disease activity test on clinical practice.

Authors:  John W Peabody; Vibeke Strand; Riti Shimkhada; Rachel Lee; David Chernoff
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

8.  Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis.

Authors:  You Jung Ha; Eun-Jin Kang; Sang-Won Lee; Soo-Kon Lee; Yong-Beom Park; Jung-Soo Song; Sang Tae Choi
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

9.  Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.

Authors:  Wanying Li; Eric H Sasso; Annette H M van der Helm-van Mil; Tom W J Huizinga
Journal:  Rheumatology (Oxford)       Date:  2015-09-18       Impact factor: 7.580

10.  Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia.

Authors:  Yvonne C Lee; James Hackett; Michelle Frits; Christine K Iannaccone; Nancy A Shadick; Michael E Weinblatt; Oscar G Segurado; Eric H Sasso
Journal:  Rheumatology (Oxford)       Date:  2015-11-25       Impact factor: 7.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.